Credentialing next-generation human glioma models for precision therapeutics
认证下一代人类神经胶质瘤模型的精准治疗
基本信息
- 批准号:10830654
- 负责人:
- 金额:$ 13.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-01-01 至 2026-12-31
- 项目状态:未结题
- 来源:
- 关键词:AffinityAwardBioinformaticsBiologyChemicalsClustered Regularly Interspaced Short Palindromic RepeatsCollaborationsCombined Modality TherapyCoupledCredentialingDataDrug TargetingDrug resistanceEngineeringEpidermal Growth Factor ReceptorEpidermal Growth Factor Receptor Tyrosine Kinase InhibitorFailureFoundationsGenetic EngineeringGliomaGoalsHumanImmobilizationInvestigational TherapiesIsotopesKineticsMalignant NeoplasmsMass Spectrum AnalysisMeasuresModelingMolecularMonitorParentsPeptidesPhosphorylationPhosphotransferasesPre-Clinical ModelPrecision therapeuticsPrimary Brain NeoplasmsProtein-Serine-Threonine KinasesProteinsProteomicsReactionSamplingSepharoseSerineTechnologyTherapeutic UsesTyrosineTyrosine Kinase InhibitorUpdateWorkcombatdesignexperiencegenome editinginduced pluripotent stem cellinhibitorinsightinterestmicrochipmodel designmutantnext generationnext generation sequencingnovelpreclinical developmentresponsesmall moleculesuccesstime usetreatment responsetumor
项目摘要
ABSTRACT
This application is being submitted in response to the Notice of Special Interest (NOSI) identified as NOT-
CA-23-045. Despite notable successes in other cancers, precision therapeutics have failed in EGFR-driven
gliomas, the most common and deadly primary brain tumors. Reasons for failure include the lack of
preclinical models that faithfully recapitulate the biology of EGFR-driven gliomas and adaptive responses to
therapy. Through our multi-PI (MPI) parent award R01 CA258248, we are developing and molecularly
credentialing novel EGFR mutant-driven human glioma models for use in preclinical development of
tyrosine kinase inhibitor (TKI)-based therapies. The foundation of our modeling work comes from the
Furnari Lab (UCSD), who developed a novel platform for engineering glioma models from human induced
pluripotent stem cells (iPSC) using CRISPR genome editing. The Miller Lab has extensive experience in
small molecule experimental therapeutics using genetically engineered (GE) glioma models, next-
generation sequencing, and proteomics. Our parent award proposed to leverage our established
collaboration with the Johnson Lab (UNC) to profile kinase expression en masse using multiplex inhibitor
beads coupled with mass spectrometry (MIB-MS). We previously used this approach to show that dynamic
kinome reprogramming contributes to targeted drug resistance in glioma models. In this Multi-PI
supplement, we will extend our originally proposed work through integration of two distinct, but
complementary kinome profiling approaches. The Johnson Lab has developed an updated version of MIB-
MS termed SureQuant. MIB-MS requires affinity-based enrichment of active kinases using broad-spectrum
inhibitors chemically coupled to Sepharose beads and is limited to relative quantification of kinase
expression. SureQuant uses isotopically “heavy” peptides, designed from MIB-enriched, proteolytically
digested human kinases, and parallel reaction monitoring (PRM) to absolutely quantify kinase expression
in otherwise un-enriched protein samples. This advance will be coupled with a second complimentary
approach: the PamStation technology from the Kinome Core (Willey Lab) at UAB. This approach monitors
the kinetics of tyrosine or serine/threonine kinase activity (phosphorylation) in real time using specific
peptide substrates immobilized on microchips. Thus, whereas SureQuant accurately measures kinase
expression, PamStation monitors substrate-level kinase activity. We hypothesize that a combination of
these two approaches, and bioinformatic integration of the resulting data, will provide novel insights into the
glioma kinome and its dynamic response to targeted EGFR TKI.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Frank Furnari其他文献
Frank Furnari的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Frank Furnari', 18)}}的其他基金
Credentialing next-generation human glioma models for precision therapeutics
认证下一代人类神经胶质瘤模型的精准治疗
- 批准号:
10549346 - 财政年份:2022
- 资助金额:
$ 13.15万 - 项目类别:
Credentialing next-generation human glioma models for precision therapeutics
认证下一代人类神经胶质瘤模型的精准治疗
- 批准号:
10375043 - 财政年份:2022
- 资助金额:
$ 13.15万 - 项目类别:
Genotypic Interactions in Brain Cancer Heterogeneity
脑癌异质性中的基因型相互作用
- 批准号:
10375989 - 财政年份:2012
- 资助金额:
$ 13.15万 - 项目类别:
Genotypic Interactions in Brain Cancer Heterogeneity
脑癌异质性中的基因型相互作用
- 批准号:
8538528 - 财政年份:2012
- 资助金额:
$ 13.15万 - 项目类别:
Genotypic Interactions in Brain Cancer Heterogeneity
脑癌异质性中的基因型相互作用
- 批准号:
9086438 - 财政年份:2012
- 资助金额:
$ 13.15万 - 项目类别:
Genotypic Interactions in Brain Cancer Heterogeneity
脑癌异质性中的基因型相互作用
- 批准号:
10799994 - 财政年份:2012
- 资助金额:
$ 13.15万 - 项目类别:
Genotypic Interactions in Brain Cancer Heterogeneity
脑癌异质性中的基因型相互作用
- 批准号:
8420244 - 财政年份:2012
- 资助金额:
$ 13.15万 - 项目类别:
Genotypic Interactions in Brain Cancer Heterogeneity
脑癌异质性中的基因型相互作用
- 批准号:
8677987 - 财政年份:2012
- 资助金额:
$ 13.15万 - 项目类别:
Genotypic Interactions in Brain Cancer Heterogeneity
脑癌异质性中的基因型相互作用
- 批准号:
9899325 - 财政年份:2012
- 资助金额:
$ 13.15万 - 项目类别:
Genotypic Interactions in Brain Cancer Heterogeneity
脑癌异质性中的基因型相互作用
- 批准号:
10454095 - 财政年份:2012
- 资助金额:
$ 13.15万 - 项目类别:
相似海外基金
Open Access Block Award 2024 - Durham University
2024 年开放访问区块奖 - 杜伦大学
- 批准号:
EP/Z531480/1 - 财政年份:2024
- 资助金额:
$ 13.15万 - 项目类别:
Research Grant
Open Access Block Award 2024 - Goldsmiths College
2024 年开放获取区块奖 - 金史密斯学院
- 批准号:
EP/Z531509/1 - 财政年份:2024
- 资助金额:
$ 13.15万 - 项目类别:
Research Grant
Open Access Block Award 2024 - John Innes Centre
2024 年开放访问区块奖 - 约翰·英尼斯中心
- 批准号:
EP/Z53156X/1 - 财政年份:2024
- 资助金额:
$ 13.15万 - 项目类别:
Research Grant
Open Access Block Award 2024 - London School of Economics & Pol Sci
2024 年开放获取区块奖 - 伦敦政治经济学院
- 批准号:
EP/Z531625/1 - 财政年份:2024
- 资助金额:
$ 13.15万 - 项目类别:
Research Grant
Open Access Block Award 2024 - Oxford Brookes University
2024 年开放获取区块奖 - 牛津布鲁克斯大学
- 批准号:
EP/Z531728/1 - 财政年份:2024
- 资助金额:
$ 13.15万 - 项目类别:
Research Grant
Open Access Block Award 2024 - The Francis Crick Institute
2024 年开放获取区块奖 - 弗朗西斯·克里克研究所
- 批准号:
EP/Z531844/1 - 财政年份:2024
- 资助金额:
$ 13.15万 - 项目类别:
Research Grant
Open Access Block Award 2024 - The Natural History Museum
2024 年开放访问区块奖 - 自然历史博物馆
- 批准号:
EP/Z531856/1 - 财政年份:2024
- 资助金额:
$ 13.15万 - 项目类别:
Research Grant
Open Access Block Award 2024 - University of Brighton
2024 年开放获取区块奖 - 布莱顿大学
- 批准号:
EP/Z531935/1 - 财政年份:2024
- 资助金额:
$ 13.15万 - 项目类别:
Research Grant
Open Access Block Award 2024 - University of Bristol
2024 年开放获取区块奖 - 布里斯托大学
- 批准号:
EP/Z531947/1 - 财政年份:2024
- 资助金额:
$ 13.15万 - 项目类别:
Research Grant
Open Access Block Award 2024 - University of Bradford
2024 年开放获取区块奖 - 布拉德福德大学
- 批准号:
EP/Z531923/1 - 财政年份:2024
- 资助金额:
$ 13.15万 - 项目类别:
Research Grant














{{item.name}}会员




